Sionna Therapeutics (NASDAQ:SION) Trading Up 13.5% – What’s Next?

Sionna Therapeutics, Inc. (NASDAQ:SION) shot up 13.5% during mid-day trading on Wednesday . The company traded as high as $11.78 and last traded at $11.53. 73,565 shares traded hands during trading, a decline of 68% from the average session volume of 227,631 shares. The stock had previously closed at $10.16.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Stifel Nicolaus started coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating and a $32.00 price objective for the company. TD Cowen initiated coverage on shares of Sionna Therapeutics in a research note on Tuesday, March 4th. They set a “buy” rating on the stock. Finally, Guggenheim initiated coverage on Sionna Therapeutics in a report on Tuesday, March 4th. They issued a “buy” rating and a $45.00 price objective on the stock.

Sionna Therapeutics Price Performance

Sionna Therapeutics (NASDAQ:SION) last announced its quarterly earnings results on Thursday, March 20th. The company reported ($3.38) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.68) by ($0.70).

About Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.